Ikarian Capital »

Beigene shares owned by Ikarian Capital

Quarter-by-quarter ownership of Beigene (BGNE) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Beigene

Tip: Access up to 7 years of quarterly data

All positions including Beigene held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beigene by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $27M 118k 224.51
2021-03-31 $60M 171k 348.08
2020-12-31 $25M 97k 258.39
2019-12-31 $13M 77k 165.77

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Beigene

Baker Bros. Advisors
Capital Research and Management Company - Division 3
Hillhouse Capital Advisors
PRIMECAP Management Company
Baillie Gifford & Co
T. Rowe Price Associates
BlackRock
BlackRock
Point72 Asset Management
Capital International
Siren
Boxer Capital
First Trust Advisors
Connor, Clark & Lunn Investment Management
Bank of America Corporation

View all funds holding Beigene